References:
-
Degradation of Cdc25A byb-TrCP during S phase and in response to DNA
damage
Luca Busino1*, Maddalena Donzelli1*, Massimo Chiesa1,Daniele
Guardavaccaro2, Dvora Ganoth3, N. Valerio Dorrello2,Avram Hershko3, Michele
Pagano2& Giulio F. Draetta11European Institute of Oncology, 435 Via
Ripamonti, 20141 Milan, Italy2Department of Pathology, MSB 599, New York
University School of Medicine andNYU Cancer Institute, 550 First Avenue, New
York, New York 10016, USA3Unit of Biochemistry, B. Rappaport Faculty of
Medicine, Technion-Israel Instituteof Technology, Haifa 31096, Israel*
"Cells that where mock-transfected or transfected withb-TrCP1/2 siRNA were
synchronised by double thymidine treatment, released from G41/S arrest in the
presence of nocodazole and analysed over time for Cdc25A. As they progressed
through S phase, cells treated withb-TrCP1/2 siRNA showed a substantial
accumulation of Cdc25A as compared to mock-transfected cells, as well as a
failure to degrade the APC inhibitor Emi1 (also known as Fbx5), a target
ofb-TrCP in early mitosis(refs 1 and 2 ).To analyse the kinetics of Cdc25A
expression at mitotic exit andin G1 phase, mock-transfected or cells transfected
withb-TrCP1/2siRNA were synchronized by nocodazole treatment, released fromthe
mitotic block and analysed over time for Cdc25A. Cells transfected withb-TrCP1/2
siRNA had substantially more Cdc25A at mitosis than did mock-transfected cells,
but similar tocontrol cells they proceeded normally into G1 phase and degraded
both Cdc25A and cyclin B1, al be it with slower kinetics. This behaviour is
probably caused by an increase in Emi1 in cellstrans fected with b-TrCP siRNA
resulting in an indirect up-regulation of Cdc25A through inhibition of Cdh1 at
the exit of mitosis21. They directly compared the amounts of Cdc25A in
mock-transfected and cells transfected withb-TrCP1/2 and Emi1 siRNA at different
time points.
Emi1 did not affect the expression of Cdc25A protein. they also observed that
the Cdc25AKEN2mutant, which is not degraded byAPC/CCdh1, also accumulated in
cells transfected with b-TrCP1/2siRNA. Together, these data indicate that
b-TrCP-mediated degradation of Cdc25A may occur throughout S and G2, and that
this event is independent of the release of the Emi1-mediated inhibition of
Cdh1."
refs:
1. Guardavaccaro, D. et al. Control of meiotic and mitotic progression by the
F box protein
-Trcp1 in vivo. Dev. Cell 4, 799–812 (2003).
2. Margottin-Goguet, F. et al. Prophase destruction of Emi1 by the SCF
TrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow
progression beyond prometaphase. Dev. Cell 4,
813–826 (2003).
|
|
|
|
EMBO J. 2004 November 24; 23(23): 4649–4659.
Published online 2004 November 4. doi:
10.1038/sj.emboj.7600448.
2004, European Molecular Biology Organization
Functional interaction between p90Rsk2 and Emi1 contributes
to the metaphase arrest of mouse oocytes
Maria Paola Paronetto,1 Ezio Giorda,2
Rita Carsetti,2 Pellegrino Rossi,1 Raffaele Geremia,1
and Claudio Sette1a
1Department of Public Health and Cell Biology, Section of
Anatomy, University of Rome ‘Tor Vergata', Rome, Italy
2Research Center Ospedale Bambino Gesù, University of Rome
‘Tor Vergata', Rome, Italy
Received May 12, 2004; Accepted September 23, 2004.
Abstract
Vertebrate eggs arrest at metaphase of the second meiotic division before
fertilization under the effect of a cytostatic factor (CSF). This arrest is
established during oocyte maturation by the MAPK kinase module, comprised of
Mos, MEK, MAPKs and p90Rsk. Maintenance of CSF arrest at metaphase
requires inhibitors of the anaphase-promoting complex (APC) like Emi1, which
sequesters the APC activator Cdc20. Although it was proposed that the Mos
pathway and Emi1 act independently, neither one alone is sufficient to entirely
reproduce CSF arrest. Herein we demonstrate that p90Rsk2 associates
with and phosphorylates Emi1 upstream of the binding region for Cdc20, thus
stabilizing their interaction. Experiments in transfected cells and two-cell
embryos indicate that Emi1 and p90Rsk2 cooperate to induce the
metaphase arrest. Moreover, oocyte maturation was impaired by interfering with
the interaction between p90Rsk2 and Emi1 or by RNA interference of
Emi1. Our results indicate that p90Rsk2 and Emi1 functionally
interact during oocyte maturation and that the Mos pathway establishes CSF
activity through stabilization of an APC-inhibitory complex composed by Emi1 and
Cdc20 before fertilization.
Keywords: Cdc20,
CSF, fertilization, metaphase arrest, mouse oocytes
|
|
|
Introduction
In vertebrate eggs, a cytostatic factor (CSF) is responsible for the
stabilization of the cyclinB/cdc2 complex known as maturation-promoting factor
(MPF) (Masui and Markert, 1971). CSF
prevents the transition to anaphase until fertilization occurs and can induce
cytostatic arrest when injected into the cytoplasm of mitotically dividing
blastomeres (reviewed in
Masui, 2001). A breakthrough in the molecular characterization of CSF
came with the identification of Mos, a serine-threonine kinase newly synthesized
during oocyte maturation and capable of inducing metaphase arrest in injected
blastomeres (Sagata
et al, 1988). Mos translation during oocyte maturation
establishes CSF arrest (Masui, 2001),
whereas Mos depletion by RNAi prevents its establishment (Dupré
et al, 2002). Moreover, the mitogen-activated protein kinase
(MAPK) pathway is necessary for the biological activity of Mos in both
Xenopus and mouse eggs (Haccard
et al, 1993; Kosako
et al, 1994; Verlhac et
al, 2000a). The downstream effector of the Mos-dependent MAPK pathway
in Xenopus eggs is p90Rsk. It was demonstrated that p90Rsk2
is the predominant Rsk isoform expressed in
Xenopus eggs and embryos and that immunodepletion of p90Rsk2
from cycling egg extracts completely abolished the CSF activity of Mos (Bhatt
and Ferrell, 1999; 2000).
Furthermore, in the absence of Mos, a CSF effect could also be obtained by
microinjection of a constitutively active p90Rsk1 isoform (Gross
et al, 1999), confirming that a p90Rsk isoform
acts downstream of Mos. The role of Mos in the establishment of cytostatic
activity appears to be evolutionarily conserved in vertebrate eggs because mice
with homozygous deletion of the mos gene ovulate oocytes that do not
arrest at metaphase and undergo spontaneous parthenogenetic activation (Colledge
et al, 1994; Hashimoto et al,
1994). In addition, both MAPK and p90Rsk are similarly activated
during meiotic maturation of mouse oocytes (Kalab
et al, 1996; Verlhac
et al, 1996), indicating conservation of the whole pathway.
Most of the data available on the molecular mechanisms of CSF arrest
have been gathered using a constitutively active p90Rsk1.
Gross et al (2000)
demonstrated that this protein inhibits the ubiquitin–ligase complex known
as anaphase-promoting complex (APC), thus preventing the complete
destruction of cyclin B at anaphase I and promoting its rapid
accumulation during meiosis II. Recent evidence suggests that the Mos
pathway inhibits the APC through activation of the spindle checkpoint (Tunquist
and Maller, 2003). The kinase Bub1 is phosphorylated and activated
by the constitutively active p90Rsk1 in vitro and in
a MAPK-dependent manner during meiotic maturation (Schwab
et al, 2001), and other components of this checkpoint, like
Mad1 and Mad2, are required for the establishment of the Mos-dependent
cytostatic arrest in Xenopus eggs (Tunquist
et al, 2002; 2003).
However, the function of the spindle checkpoint in CSF maintenance must
be distinguishable from that exerted in mitotic cells, because the
checkpoint appears active even though in metaphase-arrested oocytes
chromosomes are correctly attached with their kinetochores to
microtubules of the spindle. Moreover, in eggs, only Mad1 is required
for maintenance of CSF, whereas Mad2, the direct inhibitor of Cdc20, is
dispensable at metaphase. Thus, the connection between the endogenous
p90Rsk and Mad1 in CSF arrest is still unknown (Tunquist
et al, 2003).
One puzzling feature of the elusive CSF of vertebrate eggs is that
while the Mos/MAPK/p90Rsk pathway participates in its
establishment during meiosis II, it becomes dispensable afterwards.
Indeed, immunodepletion of p90Rsk2, or of Bub1 kinase, from
Xenopus egg extracts is not sufficient to release them from the
metaphase arrest (Bhatt and Ferrell,
1999; Tunquist et al,
2002). A possible explanation is that these kinases act upstream of
the real effectors of the cytostatic activity. In this regard, it has
been proposed that a novel regulator of the APC, Emi1, is directly
responsible of the metaphase arrest of Xenopus eggs (Reimann
and Jackson, 2002). Emi1 interacts with the substrate-binding region
of Cdc20 and stabilizes mitotic cyclins in Xenopus egg extracts
(Reimann
et al, 2001a; 2001b).
Moreover, immunodepletion of Emi1 from these extracts caused degradation
of MPF and release from the CSF arrest, whereas an excess of Emi1
blocked release of CSF arrest by Ca++ or activation of CamKII
(Reimann and Jackson, 2002),
events that mimic egg activation at fertilization (Lorca
et al, 1993;
Markoulaki et al, 2003).
Thus, since Emi1 appeared both necessary and sufficient to produce CSF
activity in Xenopus egg extracts, it was proposed that this
protein was the long-sought CSF responsible for the metaphase II arrest
of vertebrate eggs (Reimann and
Jackson, 2002).
Surprisingly, the activity of Emi1 in egg extracts did not require the
Mos/MAPK/p90Rsk pathway, suggesting that Emi1 acts
independently (Reimann and Jackson,
2002). However, it remains unclear why in the absence of Mos the
cytostatic activity of vertebrate eggs does not develop (Colledge
et al, 1994; Hashimoto
et al, 1994; Dupré et
al, 2002) and why mitotic cells, which express Emi1 in the G2
phase like the oocytes, do not arrest at metaphase (Hsu
et al, 2002). Emi1 accumulates in the S and G2 phases of
mitotic cycles and its destruction at the onset of the M phase allows
progression through mitosis. Phosphorylation of Emi1 by Cdc2 in
prometaphase promotes its interaction with the substrate adaptor protein
βTrCP and its degradation by the SCF (Skp1/Cullin/F-box)
ubiquitin–ligase complex (Margottin-Goguet
et al, 2003), dictating the timing of entry into mitosis.
However, in meiosis, Emi1 is stable throughout maturation of Xenopus
oocytes (Reimann and Jackson, 2002)
but cyclin B stabilization and metaphase arrest occur only in the second
division, after full activation of the Mos pathway. Mos being the only
component of CSF selectively expressed during the meiotic divisions (Masui,
2001), it is possible that its pathway functionally interacts with
Emi1 during maturation when CSF appears.
Herein we provide evidence that phosphorylation of Emi1 by p90Rsk2
stabilizes its interaction with the APC activator Cdc20 and that the two
proteins cooperate to establish CSF arrest during mouse oocyte
maturation. Our studies provide a direct link between components
involved in the establishment and maintenance of CSF activity before
fertilization.
|
| |
Results
p90Rsk2 directly interacts with Emi1
Since p90 Rsk2 and Emi1 are both involved in cytostatic activity
in Xenopus eggs, we initially investigated whether they are
also present in mouse eggs. RT–PCR analysis from metaphase-arrested
oocytes revealed that p90 Rsk2 and Emi1 are both present at
the mRNA level (data not shown). Both proteins were detected in mouse
oocytes by Western blot ( Figure
1A) and immunofluorescence analyses showed that they were diffuse in
the cytoplasm ( Figure
1B). Moreover, both Emi1 and p90 Rsk2 seemed to decorate
the meiotic spindle ( Figure
1B, insets), suggesting that they could partially colocalize.
Next, we investigated whether Emi1 and p90Rsk2 physically
interact. The mouse Emi1 homologue was cloned by RT–PCR from a 13 days
postcoitum (dpc) embryo library and its identity was verified by direct
sequencing. HA-tagged p90Rsk2 and myc-tagged Emi1 were
expressed in Hek293 cells either alone or in combination. When cell
extracts were immunoprecipitated with anti-myc antibody, p90Rsk2
was specifically co-immunoprecipitated with myc-Emi1 (Figure
2A). Interestingly, we found that Emi1 also co-immunoprecipitated
with the endogenous APC activator Cdc20, and that coexpression of p90Rsk2
increased this association (Figure
2A).
Hence, we analysed the regions of Emi1 required for this interaction
using pull-down experiments with purified GST-Emi1 proteins. Emi1
contains an N-terminal region (aa 1–181 in mouse Emi1) upstream of the
degradation box (F-box, aa 182–236) and a C-terminal region that
contains a zinc-binding motif rich in cysteines (aa 313–383). Mitotic
cyclins bind to the N-terminal region of Xenopus Emi1, whereas
both the N-terminal and the C-terminal regions of Emi1 interact with
Cdc20 (Reimann
et al, 2001a). Remarkably, only the C-terminal region of Emi1
acts as a Cdc20 inhibitor and is necessary and sufficient for the
cytostatic activity of Xenopus eggs (Reimann
et al, 2001a; 2001b;
Reimann and Jackson, 2002). We
found that p90Rsk2 bound to full-length Emi1 and to both
GST-Emi11–181 and GST-Emi1236–383, albeit
interaction with the C-terminal region was stronger (Figure
2C). Interestingly, while the cysteine-rich motif of mouse Emi1 was
required for efficient binding to Cdc20, its deletion did not affect the
interaction with p90Rsk2 (see GST-Emi1236–313 in
Figure 2D), indicating that the kinase binds a different site in the
C-terminus of Emi1.
p90Rsk2 phosphorylates Emi1 and promotes its interaction with
Cdc20
To test whether Emi1 was a substrate for p90 Rsk2, we incubated
a purified active form of p90 Rsk2 with purified GST-Emi1
in vitro. As shown in
Figure 3A, GST-Emi1, but not GST alone, was readily phosphorylated by
the kinase. Moreover, we found that p90 Rsk2 phosphorylated
GST-Emi1 236–383 much more efficiently than GST-Emi1 1–181,
and that the region of Emi1 upstream of the zinc-finger motif was
sufficient for phosphorylation (GST-Emi1 236–313 in
Figure 3B). An analysis of the known Emi1 gene sequences revealed that
there are only four serine/threonine residues that are conserved between
amino acids 236 and 313: ser246, thr251, thr304 and ser310 ( Figure
3C). Single substitutions of these residues with alanine showed that
only ser246 and thr251 are substrates for p90 Rsk2 ( Figure
3D). Moreover, p90 Rsk2 could still phosphorylate a
GST-Emi1 236–302
fusion protein but not GST-Emi1 294–383 ( Figure
3B). However, even when a double mutation ser246ala/thr251ala
(ST/AA) was produced, phosphorylation of GST-Emi1 236–313 was
decreased but not abolished ( Figure
3D), indicating that additional, nonconserved residues between amino
acids 236 and 302 of Emi1 are substrates for p90 Rsk2 in
vitro.
Since p90Rsk2 interacts with and phosphorylates Emi1
upstream of the binding site for Cdc20, we asked whether it influenced
their interaction. GST-Emi1 full length was bound to GSH-agarose beads
and incubated for 30 min in the absence or presence of purified p90Rsk2
to obtain nonphosphorylated or phosphorylated sources of the protein (see
Figure 3A). At the end of the incubation, beads were washed and the
kinase removed, as demonstrated by Western blot analysis (third panel).
Hence, beads were incubated with extracts of proliferating Hek293 cells,
which express high levels of Cdc20. As expected, GST-Emi1 was able to
bind to Cdc20; however, phosphorylation by p90Rsk2 strongly
increased this interaction (approximately four-fold;
Figure 4A). The same effect of phosphorylation by p90Rsk2
was observed when a GST-Emi1236–383 was used (Figure
4B), confirming that the action of p90Rsk2 is exerted on
the region of Emi1 that is necessary and sufficient for its cytostatic
activity (Reimann et al,
2001a). Remarkably, the effect of phosphorylation by p90Rsk2
was completely suppressed when the GST-Emi1236–383ST/AA mutant
(ser246ala/thr251ala) was used for Cdc20 binding assays (Figure
4C). These results suggest that phosphorylation by p90Rsk2
stabilizes the interaction of Emi1 with Cdc20.
Emi1 and p90Rsk2 cooperate to induce the metaphase arrest of
Hek293 cells
Since phosphorylation of Emi1 by p90 Rsk2 increases its ability
to interact with Cdc20 and this interaction prevents activation of the
APC, we asked if p90 Rsk2 could augment the cytostatic
activity of Emi1 in vivo. To this end, we transfected Hek293
cells with constructs for p90 Rsk2 and Emi1 either alone or in
combination. In addition, cells were cotransfected with a GFP construct
(1:10) to identify transfected cells. After 24 h from transfection,
cells were fixed, stained with Hoechst and analysed for the percentage
of mitotic cells in the GFP-positive population. Control cells
transfected with empty vectors displayed 5% of GFP-positive cells in
either prometaphase or metaphase ( Figure
5A and B); overexpression of Emi1 caused an increase of mitotic
cells to 12%, similar to that observed previously for Xenopus
Emi1 ( Reimann
et al, 2001a). Interestingly, we observed that coexpression
of Emi1 with p90 Rsk2 led to a further increase in mitotic
cells (24%). This effect is similar to that obtained with a stabilized
Emi1 mutant ( Reimann et al,
2001a) and suggests that the two proteins cooperate to delay or
arrest Hek293 cells in mitosis. Overexpression of p90 Rsk2
alone also caused a small increase in mitotic index (9 versus 5% in
control cells), which could be due to an effect of the kinase on
endogenous Emi1.
To confirm that overexpression of Emi1 and p90Rsk2 caused a
mitotic arrest in Hek293 cells, we analysed cyclin B1 expression levels
and H1 kinase activity. GFP-positive and GFP-negative cells were sorted
by FACS, and protein expression was tested in the two populations.
Overexpression of Emi1 stabilized cyclin B1 and p90Rsk2
further increased the levels of cyclin B1 (Figure
5C and D). Stabilization of cyclin B1 was already appreciated when
p90Rsk2
was transfected alone, further suggesting an effect of p90Rsk2
on endogenous Emi1. Moreover, cyclin B1 increase in cells cotransfected
with Emi1 and p90Rsk2 was accompanied by MPF activation (Figure
5C, fourth panel, and
Figure 5D). These results support the hypothesis of cooperation
between these proteins to induce the metaphase arrest.
Emi1 and p90Rsk2 cooperate to induce metaphase arrest of
early blastomeres
CSF activity has been defined by the ability of purified proteins and/or
extracts to induce cell cycle arrest when microinjected into dividing
blastomeres. To examine the cooperation between p90 Rsk2 and
Emi1 by this classical bioassay, we microinjected these purified
proteins into one blastomere of mouse two-cell embryos ( Masui,
2001). We found that microinjection of GST-Emi1 236–383
did not exert a cytostatic effect in mouse embryos, which developed to
the four-cell stage as control (not shown) or GST-injected embryos ( Figure
6B). On the other hand, microinjection of an active form of p90 Rsk2
was able to induce the typical three-cell stage arrest in 42% of
microinjected embryos ( Figure
6A and B). Remarkably, when p90 Rsk2 was coinjected with
GST-Emi1 236–383, the cytostatic effect was strongly increased
(66% arrest at the three-cell stage), indicating cooperation between the
two proteins in vivo. By contrast, GST-Emi1 236–383ST/AA
did not reinforce the kinase action, indicating that phosphorylation on
the conserved ser/thr residues of Emi1 is important for the cooperative
effect ( Figure
6B).
Since we found that GST-Emi1236–313 is phosphorylated by p90Rsk2
and is sufficient for interaction with the kinase but does not interact
with Cdc20, we reasoned that this portion could interfere with binding
of endogenous Emi1 in vivo and could compete as substrate for
p90Rsk2. Indeed, in transfected cells, coexpression of Emi1236–313
not only competed with the interaction between full-length Emi1 and p90Rsk2
but also prevented association of Cdc20 with the kinase (Figure
6C), suggesting that it blocks the formation of a stable complex
between Emi1/Cdc20 and p90Rsk2. Moreover, we found that
coinjection of GST-Emi1236–313 in two-cell embryos inhibited
the cytostatic effect exerted by p90Rsk2, with only 8% of
injected embryos blocked at the three-cell stage (Figure
6A and B).
Interaction between p90Rsk2 and Emi1 is required during
oocyte maturation
Since GST-Emi1 236–313 acts as an inhibitor of the functional
interaction between p90 Rsk2 and Emi1 in vivo, we set
out to determine the role of this interaction during oocyte maturation,
when cytostatic activity is physiologically established. Oocytes at the
germinal vesicle stage were allowed to undergo germinal vesicle
breakdown (GVBD) in culture. After GVBD, oocytes were microinjected with
either GST as control or GST-Emi1 236–313 and incubated for
additional 12–14 h to complete maturation. Control or GST-injected
oocytes reached the metaphase II arrest typical of ovulated oocytes; the
chromosomes were aligned at the equator of the meiotic spindle, which
was located at the periphery of the cell ( Figure
7A, Ba, b and C). On the contrary, microinjection of GST-Emi1 236–313
caused abnormal maturation, with 30% of the oocytes extruding a second
polar body ( Figure
7A and C). Interestingly, in some oocytes, the polar body was much
larger than normal ( Figure
7A), indicating a defect in asymmetric division similar to that
observed in mos−/− oocytes ( Choi
et al, 1996; Verlhac
et al, 2000b). Immunofluorescence analysis of GST-Emi1 236–313-injected
oocytes revealed either abnormal spindles with misaligned chromosomes ( Figure
7Bc and d) or the absence of a meiotic spindle and completion of
anaphase ( Figure
7Be). On the other hand, the GST-Emi1 236–313ST/AA mutant
did not cause alterations of meiotic progression ( Figure
7Bf and C), suggesting that it was unable to interfere with Emi1
phosphorylation in vivo. These results highlight the lack of a
normal metaphase II arrest in oocytes injected with wild-type GST-Emi1 236–313
and indicate that the functional interaction between Emi1 and p90 Rsk2
is required for normal meiotic progression.
RNAi of Emi1 interferes with mouse oocyte maturation
To test whether the morphological defects observed in maturing oocytes
injected with the GST-Emi1 236–313 were due to alterations of
Emi1 function, we set out to interfere with RNA expression in oocytes by
RNAi. It was shown that microinjection of 300–500 bp double-stranded RNA
(dsRNA) sequences in maturing mouse oocytes is capable of specifically
depleting endogenous mRNAs ( Svoboda
et al, 2000). Thus, we in vitro synthesized dsRNAs
comprising the 3′ region of mouse Emi1 mRNA, or of GFP mRNA as control,
and microinjected them into GV oocytes. Oocytes were allowed to mature
and Emi1 mRNA levels were measured in GFPdsRNA- or Emi1dsRNA-injected
oocytes. As shown in
Figure 8A, Emi1 mRNA was readily detected in GFPdsRNA-injected
oocytes, whereas it was absent in Emi1dsRNA-injected oocytes.
Interestingly, depletion of Emi1 caused similar morphological defects as
those observed by injection of GST-Emi1 236–313. We observed
that 30% of Emi1dsRNA-injected oocytes extruded a second polar body ( Figure
8C and Bb) or a much larger polar body indicating the lack of
asymmetric division as reported for mos−/− oocytes ( Figure
8Bc and d), whereas 60% of the oocytes displayed abnormal spindles
with scattered chromosomes or decondensed chromatin ( Figure
8Bc, d and C). By contrast, GFPdsRNA-injected oocytes underwent
normal maturation and arrested with a metaphase II spindle ( Figure
8Ba and C). These results indicate that oocyte maturation was
severely impaired by selectively interfering with Emi1 expression in
mouse oocytes.
|
| |
Discussion
The CSF activity present in vertebrate oocytes requires activation of the
Mos/MAPK/p90Rsk2 pathway during oocyte maturation and APCCdc20
inhibitory regulators, such as Emi1 and Mad1, to be maintained once it is
established (Reimann and Jackson, 2002;
Tunquist et al, 2003).
However, the connection between the factors required for the establishment and
the maintenance of CSF is still unclear. Herein, we report that p90Rsk2,
the effector of the Mos pathway, directly interacts with and phosphorylates
Emi1, an essential inhibitor of APC at metaphase (Reimann
and Jackson, 2002). Moreover, we show that functional interaction between
p90Rsk2 and Emi1 potentiates the ability of Emi1 to bind to Cdc20 and
to induce cytostatic arrest both in mouse blastomeres and in transfected cells.
Thus, our results establish a first direct connection between proteins involved
in the establishment and in the maintenance of cytostatic activity in vertebrate
eggs.
In vitro binding experiments, supported also by
co-immunoprecipitation experiments, indicate that phosphorylation of the
C-terminal region of Emi1 by p90Rsk2 potentiates four-fold
its ability to bind Cdc20. Notably,
Reimann and Jackson (2002) showed that cytostatic arrest was released
when recombinant Cdc20 was added to Xenopus egg extracts at 3
μM concentration, but not at 1 μM concentration, and that it was
prevented by addition of equimolar amounts of Emi1. Their results
indicate that CSF arrest is maintained by a strict balance between Emi1
and Cdc20 concentrations, and that changing this balance by as little as
three-fold triggers metaphase-to-anaphase transition. Thus, we propose
that one of the functions of the Mos pathway during oocyte maturation is
to reinforce the cytostatic activity of Emi1 through phosphorylation by
p90Rsk2
(Figure
9). Our conclusion is supported by the observations that coinjection
of Emi1 with p90Rsk2 in mouse blastomeres exerts a stronger
cytostatic effect than either protein alone. In addition, substitution
of the evolutionarily conserved ser246/thr251 residues, which are
phosphorylated by p90Rsk2, suppresses the cooperation between
the two proteins in vivo and the ability to stabilize the
Cdc20/Emi1 interaction in vitro. Our results also show that
injection of GST-Emi1236–313, which interacts with p90Rsk2
and is efficiently phosphorylated by the kinase but is unable to bind
Cdc20 efficiently, blocks the cytostatic activity of constitutively
active p90Rsk2 in two-cell embryos and it interferes with
meiosis II progression and cytostatic arrest in maturing mouse oocytes.
Since similar defects were observed when Emi1 expression was impaired by
RNAi, it seems that the effects are due to alterations of Emi1 function.
These results suggest that GST-Emi1236–313 competes for the
interaction of p90Rsk2 with endogenous Emi1 and that this
interaction is necessary for the establishment of cytostatic arrest.
The morphological examination of oocytes matured in the presence of
GST-Emi1236–313, or where Emi1 expression was decreased by
RNAi, revealed that they closely resemble mos−/− oocytes (Choi
et al, 1996; Verlhac
et al, 2000a; 2000b),
with some oocytes extruding a second polar body and others with abnormal
spindles and misaligned chromosomes or abnormal cytokinesis. Beside
stabilization of MPF activity through inhibition of the APCCdc20,
the Mos/MAPK/p90Rsk pathway is also important for
stabilization of the spindle through post-translational modifications of
microtubule-associating proteins like MISS and DOC1R (Verlhac
et al, 1996; Lefebvre
et al, 2002; Terret et al,
2003). The spindle abnormalities in oocytes injected with GST-Emi1236–313
or Emi1dsRNA suggest that the functional interaction between Emi1 and p90Rsk2
contributes also to this aspect of meiosis II. Interestingly, it has been
shown that MISS protein is stable only in metaphase II-arrested oocytes,
once the cytostatic activity has been established. Since the spindle
defects observed after in vivo depletion of MISS (Lefebvre
et al, 2002) closely resemble those obtained by interference
with Emi1, it would be interesting to determine whether MISS is a
substrate for the APCCdc20 and whether Emi1 prevents its
degradation in meiosis.
The only proteins shown to be required for maintenance of the
cytostatic arrest in eggs are the APCCdc20 inhibitors Emi1
and Mad1 (Reimann and Jackson, 2002;
Tunquist et al, 2003). In
both cases, the crucial experiments employed an immunodepletion approach
from Xenopus egg extracts, which are typically arrested at
metaphase with high MPF and MAPK activity. Depletion of either Mad1 or
Emi1 led to activation of the APC, cyclin B degradation and mitotic
exit. Since addition of either recombinant Mad1 or Emi1 was sufficient
to block these events, in both works it was concluded that these
proteins were necessary and sufficient to maintain the CSF arrest of
Xenopus
eggs. One possibility to reconcile this apparent paradox is that Mad1 and
Emi1 associate in a complex and depletion of either one causes mitotic
exit because of depletion of the inhibitory complex. However, it was not
checked whether or not Emi1 co-immunoprecipitates with Mad1 in the
immunodepletion experiments (Reimann
and Jackson, 2002; Tunquist
et al, 2003). Because of the limiting volume of mouse oocytes,
such approaches cannot be applied to our system. Nevertheless, our
in vivo
competition and/or depletion approaches suggest that Emi1 participates in
cytostatic arrest also in mouse oocytes.
Our observations suggest that the metaphase-to-anaphase transition in
vertebrate eggs is controlled by a relay of phosphorylation events that
fine-tune the reciprocal affinity of regulatory components of the APC.
In our model, p90Rsk2 is activated by the Mos pathway during
oocyte maturation and phosphorylates Emi1, increasing its affinity for
Cdc20 and preventing activation of the APC (Figure
9). After metaphase is reached, the Mos pathway becomes dispensable
(Tunquist and Maller, 2003),
possibly because phosphorylated Emi1 is stable in the oocyte
environment. This might be due to the absence of a counteracting
phosphatase or to inaccessibility of Emi1 when complexed to Cdc20. In
agreement with this second hypothesis, it was noted that Emi1 has a
stronger affinity for the APC activator Cdh1 than for Cdc20, and it is
rapidly degraded when Cdh1 disappears (Reimann
et al, 2001b; Hsu et
al, 2002). Since only Cdc20 is present in oocytes (Lorca
et al, 1998), it is possible that phosphorylation by p90Rsk2
prolongs Emi1 life in meiosis through the stabilization of the normally
loose interaction with Cdc20. At fertilization, activation of CaMKII
triggers activation of APCCdc20 and degradation of cyclin B (Lorca
et al, 1993). It remains to be established whether CaMKII
acts directly through phosphorylation of Emi1 or Cdc20 and whether
phosphorylation causes dissociation of the complex. In this regard, our
preliminary data suggest that at least Emi1 is not a direct in vitro
substrate for CamKII (MP Paronetto and C Sette, unpublished observation).
In conclusion, our results indicate that p90Rsk2
functionally interacts with Emi1 in the establishment of CSF activity in
mouse eggs. Our model offers a reconciling view on the connection
between two components of CSF that were previously considered
independent, leaving puzzling doubts on the relation between the
establishment and the maintenance of CSF arrest (Duesbery
and Vande Woude, 2002). Moreover, since activation of the MAPK
pathway is required also in the response to the spindle- and DNA-damage
checkpoints in mitotic cells (Chung
and Chen, 2003;
Panta et al, 2004), our
results may provide a direct link between this pathway and cell cycle
arrest through the inhibition of the APC.
|
| |
Materials and methods
Mouse Emi1 was amplified by PCR using a 13 dpc embryo cDNA library and
oligonucleotides 5′-AGGAATTCATGAAGTGTTTTAATTGCAACCCT G-3′ (forward) and
5′-GGTCGACTCACAATCTTTGTAAGTTCTTTTTA C-3′ (reverse) and subcloned into
the
EcoRI and SalI sites of either pCDNA3-myc or pGEX4T1
expression vectors for myc- or GST-tagged Emi1, respectively.
Oligonucleotides were derived from the mouse Emi1 homologue deposited in
the NCBI database (Fbxo5: NM_025995). Additional oligonucleotides used
were as follows: 5-GGTCGACTCATAGGTGCTCCAGGCCCAT-3′ (reverse) for
GST-Emi1 1–181, 5′-AGGAATTCATGCAGCGAGTCATTGAAAGC-3′ (forward)
for Emi1 236–383, 5′-GGTCGACTCAGGCTTTGAGGCTTTCGTTG-3′
(reverse) for Emi1 236–313. Point mutations in Emi1 were
introduced by using mutated oligonucleotides and PCR amplification.
Pfu polymerase (Stratagene) was used for all amplifications and
constructs sequences were verified by direct sequencing. The vector
pMT2-HAp90 Rsk2 was a generous gift of Dr Mortin Frodin.
Expression and purification of GST fusion proteins Plasmids
(pGEX-) containing GST fusion proteins were transformed into the
Escherichia coli BL21 strain, and grown at 30°C in LB medium to an OD600=0.6
before induction with 0.5 mM isopropyl-β-thiogalactopyranoside (IPTG,
Sigma-Aldrich) for 3 h. GST fusion proteins were purified from bacterial
lysates on glutathione-agarose (Sigma-Aldrich) as previously described (Sette
et al, 1998) and analysed by SDS–PAGE and Coomassie blue
staining to test purity and integrity.
Cell culture and transfections Hek293 cells were maintained in
Dulbecco's medium supplemented with 10% fetal bovine serum (FBS) (Gibco
BRL) in 90 mm dishes. Subconfluent monolayers were processed for CaPO4
transfection with 1–10 μg of the appropriate plasmids or by Fugene
(Stratagene) with 0.2–2 μg of the appropriate plasmids as previously
described (Sette et al,
2002). At 24–48 h after transfection, cells were harvested in lysis
buffer (50 mM Hepes, pH 7.5, 75 mM NaCl, 10 mM β-glycerophosphate, 2 mM
EGTA, 15 mM MgCl2, 0.1 mM sodium orthovanadate, 1 mM DTT,
0.5% Triton X-100, protease inhibitor cocktail (Sigma-Aldrich)) and
incubated for 10 min on ice. Lysates were centrifuged for 10 min at 10
000 g at 4°C and used for further analysis. Protein
concentration was determined using a protein assay kit (Bio-Rad)
following the manufacturer's instructions.
FACS sorting Transfected cells were separated based on size
(forward scatter) and green fluorescence (GFP-positive) using a
FACSVantage cell sorter (Beckton and Dickinson). Purity of GFP-positive
and -negative populations was >98%. Sorted cells were used for Western
blot analysis as described below.
Pull-down assays Cell extracts (500 μg of total proteins) were
added to 2 μg of GST fusion protein adsorbed on glutathione-agarose
(Sigma-Aldrich) in 250 μl (final volume) of lysis buffer supplemented
with 0.05% bovine serum albumin (BSA). After incubation for 90 min at
4°C under constant shaking, beads were washed three times with lysis
buffer without Triton X-100, and absorbed proteins were eluted in SDS
sample buffer (62.5 mM Tris–HCl, pH 6.8, 10% glycerol, 2% (wt/vol) SDS,
0.7 M 2-mercaptoethanol and 0.0025% (wt/vol) bromophenol blue) and
resolved on a 10% SDS–PAGE for subsequent Western blot analysis.
Immunoprecipitation assay Cell extracts (500 μg of total
proteins) were incubated with 1 μg of anti-myc antibody for 2 h at 4°C
under constant shaking. Protein A–Sepharose or protein G–Sepharose
(Sigma-Aldrich) was preadsorbed with 0.05% BSA before incubation with
the immunocomplexes for an additional hour. Hence, beads were washed
three times with lysis buffer and absorbed proteins were eluted in SDS
sample buffer for Western blot analysis.
Kinase assays For p90Rsk2 assays, 1 μg of each
GST-Emi1 fusion protein was incubated at 30°C for 20 min with the
purified active form of the kinase (5 U, Upstate Biotechnology) in
reaction buffer: 50 mM Hepes, pH 7.4, 10 mM MgCl2, 1 mM EGTA,
1 mM DTT, 10 mM β-glycerophosphate, 0.5 mM NaVO4, 50 μM ATP
and 5 μCi of
32P-γ-ATP. In some experiments, GST fusion proteins were
phosphorylated while still bound to the GSH-agarose beads and at the end
of the incubation the kinases were washed by rinsing three times with an
excess of kinase buffer (without label) before using the proteins for
pull-down assays. H1 kinase assays were performed on cell extracts of
GFP-positive Hek293 cells as previously described (Bhatt
and Ferrell, 1999).
Western blot analysis Cell extracts or immunoprecipitated
proteins were diluted in SDS sample buffer as described above and boiled
for 5 min. For oocyte extracts, 300 metaphase II oocytes/sample were
collected and immediately frozen in sample buffer. After thawing,
oocytes were sonicated and boiled before loading. Proteins were
separated on 10% SDS–PAGE gels and transferred to polyvinylidene
fluoride Immobilon-P membranes (Millipore) using a semidry blotting
apparatus (Bio-Rad). The membranes were saturated with 5% nonfat dry
milk in PBS containing 0.1% Tween 20 for 1 h at room temperature, and
incubated with the following primary antibodies (1:1000 dilution)
overnight at 4°C: mouse anti-HA (for HA-p90Rsk2, from BabCO
Berkeley antibody company); rabbit anti-actin (Sigma-Aldrich); mouse
anti-Myc (for myc-Emi1); rabbit anti-Emi1 (Gentaur); goat anti-p90Rsk2,
rabbit anti-Cdc20, rabbit anti-cyclin A2, mouse anti-cyclin-B1. Primary
antibodies were all from SantaCruz Biotechnology, unless specified
otherwise. Secondary anti-mouse or anti-rabbit IgGs conjugated to
horseradish peroxidase (Amersham) were incubated with the membranes for
1 h at room temperature at a 1:10 000 dilution in PBS containing 0.1%
Tween 20. Immunostained bands were detected by chemiluminescent method
(SantaCruz Biotechnology).
Immunofluorescence analysis Oocytes were processed for
immunofluorescence analysis using anti-tubulin antibody (1:100,
Sigma-Aldrich) or anti-Emi1 antibody (1:200, Gentaur) or anti-p90Rsk2
antibody (1:200, SantaCruz Biotechnology) as previously documented (Sette
et al, 2002).
|
| |
Oocyte collection, microinjection and in vitro culture
Two-cell embryos and GV oocytes were collected from hormonally primed
6- to 7-week-old CD1 female mice (Charles River Italia) and cultured in
M16 medium under mineral oil as previously described (Hogan
et al, 1994). Oocytes were allowed to undergo GVBD by
incubation in the absence of an exogenous cAMP source and used for
microinjection either immediately (for dsRNAi) or after GVBD
(approximately 2 h after collection). Before injection, oocytes and
embryos were washed in M2 medium and then transferred to 50 μl drops of
the same medium under mineral oil. Microinjection manipulations were
performed as previously described (Sette
et al, 1998). Briefly, into the cytoplasm of one blastomere
of a two-cell embryo we injected 2–5 pl of a purified p90Rsk2
(1–5 U, Upstate Biotechnology) together with either GST or GST-Emi1
diluted to a protein concentration of 1 mg/ml in injection buffer (20 mM
Hepes, pH 7.4, 120 mM KCl, 100 μM EGTA, 10 mM β-glycerophosphate, 1 mM
DTT, 10 μg/ml leupeptin, 10 μg/ml pepstatin). Microinjections were
performed using an Olympus invertoscope (Olympus) equipped with Hoffman
modulation contrast optics (Modulation optics Inc., Greenvale, NY) and
two Leitz mechanical micromanipulators (Leica AG, Heerbrugg,
Switzerland). After microinjections, embryos or oocytes were returned to
M16 medium drops and cultured at 37°C under a humidified atmosphere of
5% CO2
in air. At 12–14 h after injection, cells were scored for mitotic or
meiotic divisions or processed for immunofluorescence analysis.
dsRNA preparation
To generate templates for dsRNA synthesis, we employed forward and
reverse oligonucleotides containing at the 5′ end a T7 promoter
sequence. For Emi1 amplification, the following primers were designed:
forward 5′-GTAATACGACTCACTACTATAGGGCATGCAGC GAGTCA-3′; reverse
5′-GTAATACGACTCACTACTATAGGGCTCACAAT CTTTGT. These oligonucleotides
amplify a region of 447 bp from base 945 to 1392 at the 3′ end of mouse
Emi1 (AK011820).
For GFP amplification, the following primers were designed: forward
5′-GTAATACGACTCACTACTATAGGGCATGCATA AAGGAG-3′; reverse
5′-GTAATACGACTCACTACTATAGGGCTCAATGC ATTAGTTC-3′. These oligonucleotides
amplify a region of 600 bp of the GFP sequence. pCDNA3-mycEmi1 and
pCMV5-GFP expression vectors were used as templates for PCR
amplification. Amplified bands were gel-purified and used as templates
(1 μg) for in vitro RNA transcription in order to obtain sense
and antisense RNA sequences as previously described (Svoboda
et al, 2000). RNA was extracted and precipitated by standard
procedures and dissolved in RNAse-free H2O. Equimolar amounts
of sense and antisense RNA were annealed in DEPC-water supplemented with
1 U/μl of RNasin (Invitrogen) and 4 μg of RNA was boiled for 1 min and
allowed to cool down at room temperature before phenol/chloroform
extraction and ethanol precipitation. dsRNA was resuspended in H2O,
assayed by agarose electrophoresis and stored at −80°C prior to use.
|
| |
Acknowledgments
We thank Drs Francesco Cenci and Federica Capolunghi for their help with
FACS analysis, Drs Manuela Pellegrini and Susanna Dolci for critically reading
the manuscript and Dr Mortin Frodin for the gift of the pMT2-HA-p90Rsk2
vector. This work was supported by MIUR Cofin 2002 and 2003.
|
|
|
References
|
|